NCT05596344Recruiting
Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors
A Single-center, Real-world Prospective Observational Study of the Incidence and Development of Anxiety and Depression in Patients With Malignant Tumors
Source: ClinicalTrials.gov · Last updated 13 Nov 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study was a single-center prospective, real-world observational study with plans to enroll all eligible patients. The basic information, anxiety and depression, treatment and prognosis of these patients were collected.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 24 Oct 2022
- Start date
- 20 May 2023
- Primary completion date
- 30 Nov 2032
- Lead sponsor
- Henan Cancer Hospital
- Diseases
- Childhood cancers
- NCT number
- NCT05596344
What you commit to
- Study type: Observational
- Planned participants: 200
- From 20 May 2023 to the primary completion date, 30 Nov 2032
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- 1.There was no pathological report of malignancy.
Who the study is looking for
- Men and women of all ages are welcome.
- Pathological diagnosis of malignant tumor in our hospital.
- Received at least one hospitalization at this hospital.
- The expected survival time is greater than 1 year.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Bone and Soft Tissue ,Henan Cancer Hospital Coordinator of this site? Confirm its status | Zhengzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.